The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications.
D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D055598:Chemical Phenomena; D002621:Chemistry; D002698:Chloralose; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004952:Esters; D005260:Female; D005703:Gallamine Triethiodide / Q000008:administration & dosage; D006221:Halothane; D000882:Haplorhini; D006339:Heart Rate / Q000187:drug effects; D008251:Macaca; D008297:Male; D009020:Morphine; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D010424:Pentobarbital; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D000605:Amino Alcohols; D004952:Esters; D003473:Neuromuscular Nondepolarizing Agents; D000644:Quaternary Ammonium Compounds; D002698:Chloralose; D009020:Morphine; D010424:Pentobarbital; D013390:Succinylcholine; D005703:Gallamine Triethiodide; D006221:Halothane; D014403:Tubocurarine